普罗米修斯实验室发现药物清除率比水平更好地预测IBD治疗结果. Prometheus Labs finds drug clearance predicts IBD treatment outcomes better than levels.

普罗米修斯实验室在2026年消化疾病周上提出了新的数据,表明测量药物清除率为个性化的炎症肠病治疗提供了关键的见解. Prometheus Laboratories presented new data at Digestive Disease Week 2026 indicating that measuring drug clearance provides critical insights for personalizing inflammatory bowel disease treatments. 一项对3000多名患者的研究发现清除与炎症比单独药物水平更有强烈联系,而前性研究显示它可以预测治疗失败. A study of over 3,000 patients found clearance is more strongly linked to inflammation than drug levels alone, while a prospective study showed it helps predict treatment failures. 该公司还分享了关于胃肠道疾病的非侵入性诊断研究. The company also shared research on non-invasive diagnostics for gastrointestinal conditions.